Laparoscopic gastrectomy for patients with advanced gastric cancer produces oncologic outcomes similar to those for open resection

被引:34
作者
MacLellan, S. J. [1 ]
MacKay, H. J. [2 ]
Ringash, J. [2 ]
Jacks, L. [3 ]
Kassam, Z. [2 ]
Conrad, T. [2 ]
Khalili, I. [4 ]
Okrainec, A. [1 ]
机构
[1] Univ Hlth Network, Toronto Western Hosp, Toronto, ON M5T 2S8, Canada
[2] Univ Hlth Network, Princess Margaret Hosp, Toronto, ON M5G 2M9, Canada
[3] Univ Hlth Network, Dept Biostat, Toronto, ON M5G 2M9, Canada
[4] Univ Hlth Network, Dept Med Imaging, Toronto, ON M5G 2C4, Canada
来源
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES | 2012年 / 26卷 / 07期
关键词
Adjuvant chemoradiotherapy; Advanced gastric cancer; Laparoscopic gastrectomy; Recurrence pattern; ASSISTED DISTAL GASTRECTOMY; BILLROTH-I GASTRECTOMY; LYMPH-NODE DISSECTION; OPEN SUBTOTAL GASTRECTOMY; QUALITY-OF-LIFE; ADJUVANT CHEMOTHERAPY; D2; LYMPHADENECTOMY; CLINICAL-TRIAL; INTERIM-REPORT; SURGERY;
D O I
10.1007/s00464-011-2118-y
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Laparoscopic gastrectomy has gained acceptance as treatment for early gastric cancer. However, its role for advanced gastric cancer remains unclear. This study aimed to compare the oncologic outcomes between laparoscopic and open gastrectomy in the management of advanced gastric cancer for patients receiving adjuvant chemoradiotherapy. Methods This study reviewed consecutive patients treated with gastric cancer resection and adjuvant chemoradiation (45 Gy/25 with 5-fluorouracil [FU]-based chemotherapy), at a quaternary care comprehensive cancer center between 1 Jan 2000 and 30 Nov 2009. Of 203 patients, 21 were treated with laparoscopic gastrectomy. These patients were compared with patients who had open surgery and evaluated for overall survival, relapse-free survival, and site of first disease recurrence. Results The 21 patients in the laparoscopic group had a median age of 61.3 years (range, 28.2-76.6 years) and a median follow-up period of 21.3 months (range, 6.7-50.4 months). The majority of the patients (71%) were men. Most of these patients had tumor node metastasis (TNM) v6 stage 2 (33%) or 3 (52%) disease as classified by the American Joint Committee on Cancer (AJCC) and the Union for International Cancer Control (UICC). The demographic characteristics of the laparoscopic and open groups were similar. The incidence of recurrence was 38.1% (8/21) in the laparoscopic group and 36.8% (67/182) in the open group. In the laparoscopic group, the site of first recurrence was distant in three patients, peritoneal in four patients, and mixed in one patient (locoregional and distant). The recurrence patterns did not differ significantly between the laparoscopic and open surgery groups. In the open group, recurrence was distant in 26 patients, peritoneal in 12 patients, and locoregional in 15 patients. At presentation, 14 patients showed a mixed pattern. The 3-year relapse-free survival rate was 58% (range, 50-66%), and the difference between the two groups by Gray's test was not significant (P = 0.32). The 3-year overall survival rate was 65.9% (range, 58-73%) and did not differ significantly between the two groups in the univariate (P = 0.92) or multivariate (P = 0.54) analysis. Conclusion The study findings suggest that laparoscopic gastrectomy is an oncologically safe procedure for advanced gastric cancer with outcomes similar to those for open resection.
引用
收藏
页码:1813 / 1821
页数:9
相关论文
共 52 条
  • [1] Quality of life after laparoscopy-assisted Billroth I gastrectomy
    Adachi, Y
    Suematsu, T
    Shiraishi, N
    Katsuta, T
    Morimoto, A
    Kitano, S
    Akazawa, K
    [J]. ANNALS OF SURGERY, 1999, 229 (01) : 49 - 54
  • [2] Laparoscopy-assisted Billroth I gastrectomy compared with conventional open gastrectomy
    Adachi, Y
    Shiraishi, N
    Shiromizu, A
    Bandoh, T
    Aramaki, M
    Kitano, S
    [J]. ARCHIVES OF SURGERY, 2000, 135 (07) : 806 - 810
  • [3] Assessment of Open Versus Laparoscopy-Assisted Gastrectomy in Lymph Node-Positive Early Gastric Cancer: A Retrospective Cohort Analysis
    An, Ji Yeong
    Heo, Geon-Ung
    Cheong, Jae-Ho
    Hyung, Woo Jin
    Choi, Seung Ho
    Noh, Sung Hoon
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2010, 102 (01) : 77 - 81
  • [4] Extended lymph-node dissection for gastric cancer
    Bonenkamp, JJ
    Hermans, J
    Sasako, M
    van de Velde, CJH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (12) : 908 - 914
  • [5] Etiology of Delays in the Initiation of Adjuvant Chemotherapy and Their Impact on Outcomes for Stage II and III Rectal Cancer
    Cheung, Winson Y.
    Neville, Bridget A.
    Earle, Craig C.
    [J]. DISEASES OF THE COLON & RECTUM, 2009, 52 (06) : 1054 - 1063
  • [6] Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
    Cunningham, David
    Allum, William H.
    Stenning, Sally P.
    Thompson, Jeremy N.
    Van de Velde, Cornelis J. H.
    Nicolson, Marianne
    Scarffe, J. Howard
    Lofts, Fiona J.
    Falk, Stephen J.
    Iveson, Timothy J.
    Smith, David B.
    Langley, Ruth E.
    Verma, Monica
    Weeden, Simon
    Chua, Yu Jo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (01) : 11 - 20
  • [7] Patterns of initial recurrence in completely resected gastric adenocarcinoma
    D'Angelica, M
    Gonen, M
    Brennan, MF
    Turnbull, AD
    Bains, M
    Karpeh, MS
    [J]. ANNALS OF SURGERY, 2004, 240 (05) : 808 - 816
  • [8] Full Robotic Gastrectomy with Extended (D2) Lymphadenectomy for Gastric Cancer: Surgical Technique and Preliminary Results
    D'Annibale, Annibale
    Pende, Vito
    Pernazza, Graziano
    Monsellato, Igor
    Mazzocchi, Paolo
    Lucandri, Giorgio
    Morpurgo, Emilio
    Contardo, Tania
    Sovernigo, Gianna
    [J]. JOURNAL OF SURGICAL RESEARCH, 2011, 166 (02) : E113 - E120
  • [9] A population-based study of tumor-node relationship, resection margins, and surgeon volume on gastric cancer survival
    de Gara, CJ
    Hanson, J
    Hamilton, S
    [J]. AMERICAN JOURNAL OF SURGERY, 2003, 186 (01) : 23 - 27
  • [10] Deogracias ML, 2006, REV ESP ENFERM DIG, V98, P755, DOI 10.4321/s1130-01082006001000005